TEL gene rearrangements in myeloid malignancy

Hematology/Oncology Clinics of North America

Volumn 11, Issue 6, 1997, Pages 1207-1220

  Golub, T R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD34 ANTIGEN; CD7 ANTIGEN; CYTOKINE RECEPTOR; DNA; HELIX LOOP HELIX PROTEIN; HLA DR ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MICROSOMAL AMINOPEPTIDASE; POLYPEPTIDE; PROTEIN; PROTEIN TYROSINE KINASE; STEM CELL FACTOR; TRANSCRIPTION FACTOR;

CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; DNA BINDING; ELECTROPHORETIC MOBILITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; LEUKEMOGENESIS; MYELOID LEUKEMIA; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSACTIVATION;

EID: 0031473397     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70490-1     Document Type: Article

References (57)

1. M. Baens P. Peeters C. Guo Genomic organization of TEL: The human ETS-variant gene 6 Genome Res 6 1996 404 413
2. M. Berkowicz E. Rosner C. Rechavi Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12): A new association? Cancer Genet Cytogenet 51 1991 277 278
3. A.P. Bradford C. Wasylyk B. Wasylyk Interaction of Ets-1 and POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression Mol Cell Biol 17 1997 1065 1074
4. A. Buijs S. Sherr van Baal S. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11 Oncogene 10 1995 1511 1519
5. M. Carroll M.H. Thomasson G.F. Barker The TEL/PDGFRβ fusion in CMML is a transforming protein which self-associates and activates PDGFRβ kinase-dependent signaling pathways Proc Natl Acad Sci USA 93 1996 14845 14850
6. P. Erickson J. Gao K.S. Chang Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt Blood 80 1992 1825 1831
7. S. Fears M. Gavin Zhang D.-E. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter Proc Natl Acad Sci USA 94 1997 1949 1954
8. D. Fitzsimmons W. Hodsdon W. Wheat Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter Genes Dev 10 1996 2198 2211
9. C.K. Galang C.J. Der C.A. Hauser Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites Oncogene 9 1994 2913 2921
10. K. Giese C. Kingsley J. Kirschner Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions Genes Dev 9 1995 995 1008
11. T.R. Golub G.F. Barker S.K. Bohlander Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia Proc Natl Acad Sci USA 92 1995 4917 4921
12. T.R. Golub G.F. Barker M. Lovett Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 77 1994 307 316
13. T. Golub A. Goga G. Barker Oligomerization of the ABL tyrosine kinase by the ETS protein TEL in human leukemia Mol Cell Biol 16 1996 4107 4116
14. H. Harada Y. Harada M. Eguchi Characterization of acute leukemia with t(4;12) Leuk Lymphoma 25 1997 47 53
15. Heldin C.-H. A. Ernlund C. Rorsman Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation J Biol Chem 264 1989 8905 8912
16. S.W. Hiebert Sun W.-H. N. Davis The t(12;21) converts AML-1B from an activator to a repressor of transcription Mol Cell Biol 16 1996 1349 1355
17. C. Jousset C. Carron A. Boureux A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein EMBO J 16 1997 69 82
18. P. Keene B. Mendelow M.R. Pinto Abnormalities of chromosome 12p13 and malignant proliferation of eosinophils: A nonrandom association Br J Haematol 67 1987 25 31
19. R.H. Lekanne-Deprez P.H. Riegman N.A. Groen Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma Oncogene 10 1995 1521 1528
20. R. Lerza G. Castello M. Sessarego Myelodysplastic syndrome associated with increased bone marrow fibrosis and translocation (5;12)(q33;p12-3) Br J Haematol 82 1992 476 477
21. P. Liu S.A. Tarle A. Hajra Fusion between transcription factor CBFB/PEBP2B and a myosin heavy chain in acute myeloid leukemia Science 261 1993 1041 1044
22. T. McLean S. Ringold K. Stegmaier TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia Blood 88 1996 4252 4258
23. K. Mitani S. Ogawa T. Tanaka Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia EMBO J 13 1994 504 510
24. H. Miyoshi K. Shimizu T. Kozu t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1 Proc Natl Acad Sci USA 88 1991 10431 10434
25. K. Morishita D.S. Parker M.L. Mucenski Retroviral activation of a novel gene encoding a zinc finger protein in IL-3 dependent myeloid leukemia cell lines Cell 54 1988 831 840
26. G. Nucifora C.R. Begy P. Erickson The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1 Proc Natl Acad Sci USA 90 1993 7784 7788
27. G. Nucifora C.R. Begy H. Kobayashi Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations Proc Natl Acad Sci USA 91 1994 4004 4008
28. M. Nunn P.H. Seeburg C. Moscovici Tripartite structure of the avian erythroblastosis virus E26 transforming gene Nature 306 1983 391 395
29. J.A. Nye J.M. Petersen C.V. Gunther Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif Genes Dev 6 1990 975 990
30. K. Okuda T.R. Golub D.G. Gilliland p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines Oncogene 13 1996 1147 1152
31. E. O'Neill I. Rebay R. Tjian The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway Cell 78 1994 137 147
32. P. Papadopoulos S.A. Ridge C.A. Boucher The novel activation of ABL by fusion to an ets-related gene, TEL Cancer Res 55 1995 34 38
33. P. Peeters I. Wlodarska M. Baens Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders Cancer Res 57 1997 564 569
34. H. Poirel C. Oury C. Carron The TEL gene products: Nuclear phosphoproteins with DNA binding properties Oncogene 14 1997 349 357
35. B. Rabault J. Ghysdael Calcium-induced phosphorylation of ETS1 inhibits its specific DNA J Biol Chem 269 1994 28143 28153
36. S. Raynaud H. Cave M. Baens The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia Blood 87 1996 2891 2899
37. I. Rebay G.M. Rubin Yan functions as a general inhibitor of differentiation and is negatively regulated by activation of the Ras1/MAPK pathway Cell 81 1995 857 866
38. S.P. Romana M. Mauchauffe Le Coniat M. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion Blood 85 1995 3662 3670
39. S.P. Romana H. Poirel M. Leconiat High frequency of the t(12;21) in childhood B-lineage acute lymphoblastic leukemia Blood 86 1995 4263 4269
40. J.E. Rubnitz F.G. Behm C.H. Pui Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, ETV6 gene abnormalities: Results of St Jude Total Therapy Study XII Leukemia 11 1997 1201 1206
41. J.E. Rubnitz J.R. Downing C.H. Pui TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance J Clin Oncol 15 1997 1150 1157
42. J.E. Rubnitz J.J. Shuster V.J. Land Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A Pediatric Oncology Group study Blood 89 1997 1143 1146
43. Y. Sato Y. Suto J. Pietenpol TEL and KIP1 define the smallest region of deletions in 12p13 in hematopoietic malignancies Blood 86 1995 1525 1533
44. A. Seth T.S. Papas The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated Oncogene 5 1990 1761 1767
45. S.A. Shurtleff A. Buijs F.G. Behm TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common getic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis Leukemia 9 1995 1985 1989
46. M.H. Sieweke H. Tekotte J. Frampton MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation Cell 85 1996 49 60
47. A. Srivastava H. Boswell N.A. Heerema KRAS2 Oncogene overexpression in myelodysplastic syndrome with translocation 5;12 Cancer Genet Cytogenet 35 1988 61 71
48. M.J. Thirman H.J. Gill R.C. Burnett Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations N Engl J Med 329 1993 909 914
49. L.C. Wang F. Kuo Y. Fujiwara Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL EMBO J 14 1997 4374 4383
50. J.W. Wessels W.E. Fibbe van der Keur D. t(5;12)(q31;p12) A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia Cancer Genet Cytogenet 65 1993 7 11
51. D.A. Wilkinson G.A.M. Neale S. Mao Elf-2, a rhombotin-2 binding ets transcription factor: Discovery and potential role in T cell leukemia Leukemia 11 1997 86 96
52. I. Wlodarska P. Marynen La Starza R. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberrations in different hematological malignancies Cytogenet Cell Genet 72 1996 229 235
53. I. Wlodarska C. Mecucci P. Marynen TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12) (q33;p13) translocation or its variant t(10;12) (q24;p13) Blood 85 1995 2848 2852
54. D. Wotton J. Ghysdael S. Wang Cooperative binding of Ets-1 and core binding factor to DNA Mol Cell Biol 14 1994 840 850
55. Yang B.-S. C.A. Hauser G. Henkel Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2 Mol Cell Biol 16 1996 538 547
56. Yan X.-Q. G. Brady N.N. Iscove Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo Oncogene 9 1994 163 173
57. C.S. Zent C. Mathieu D.F. Claxton The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties Proc Natl Acad Sci USA 93 1996 1044 1048